KYR-16879-98321 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-12
Registered in v-safe
2021-01-12
Dose 1 — Pfizer-BioNTech
2021-01-14
Survey response — days 1–6 daily, dose 1
MedDRA: Exfoliative rash, Pruritus — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Had rash in scalp day of injection and itchy palms and soles of feet

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-14
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Itching · Joint pains

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Itching · Headache

Adult check-in
2021-01-20
Health check-in — day 7, dose 1
Feeling: Fair · Site: Itching · Fever · Chills, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-26
Survey response — day 14, dose 1
MedDRA: Urticaria — Feeling: Good

Free text: Large hives

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-04
Survey response — day 21, dose 1
MedDRA: Diarrhoea — Feeling: Fair

Free text: Diarrhea

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-09
Survey response — day 28, dose 1
MedDRA: Diarrhoea — Feeling: Fair

Free text: Continued diarrhea

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-19
Survey response — day 35, dose 1
MedDRA: Diarrhoea, Headache — Feeling: Fair

Free text: Headache and continued diarrhea.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-24
Survey response — day 42, dose 1
MedDRA: Headache, Self-medication — Feeling: Good · Be unable to do your normal daily activities

Free text: Severe headaches. Lasted multiple days. Unrelieved with Tylenol or Ibuprofen.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-18
Survey response — 3 months, dose 1
MedDRA: Dizziness — Feeling: Fair · Be unable to do your normal daily activities

Free text: Dizziness.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-18
Report sent to call center — 3 months, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-07-15
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2022-01-14
Health check-in — 12 months, dose 1
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-12	Pfizer-BioNTech

Call center

2 call center cases

2 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-14

Systemic reaction (other): Had rash in scalp day of injection and itchy palms and soles of feet

Release 2 — day 14, dose 1

2021-01-26

Symptoms: Large hives

Release 3 — day 21, dose 1

2021-02-04

Symptoms: Diarrhea

Release 3 — day 28, dose 1

2021-02-09

Symptoms: Continued diarrhea

Release 4 — day 35, dose 1

2021-02-19

Symptoms: Headache and continued diarrhea.

Release 4 — day 42, dose 1

2021-02-24

Symptoms: Severe headaches. Lasted multiple days. Unrelieved with Tylenol or Ibuprofen.

Release 7 — 3 months, dose 1

2021-04-18

Symptoms: Dizziness.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Diarrhoea	✓	✓	✓
SD	Dizziness	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Self-medication	✓	✓	✓
SD	Urticaria	✓	✓	✓
SRO	Exfoliative rash	✓	✓	✓
SRO	Pruritus	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release